This finding offers a novel perspective on the relationship between AFP levels and NAFLD in patients with inactive CHB, contrary to the prevailing understanding linking elevated AFP levels with hepatic steatosis development [83,84,85,86,87]. The gene discussed is AFP; the disease is fatty liver disease.